GMP and Research-grade Vector Production

Manufacturing Biotherapeutics to GMP standard for clinical trials can be one of the most difficult hurdles to overcome. Below are a number of facilities capable of manufacturing clinical and pre-clinical grade therapeutics including plasmid, oligonucleotides and viral vectors. There are also a selection of facilities capable of conducting the range of tests necessary to meet safety standards.


Aldevron Alembic Amsterdam Molecular Technologies
Angel Bio Avecia Biologics Avigen
Bio Products Laboratory Biogenova Bioprocessing Technology Institute
Bioreliance Ltd Biotec Distribution Wales Limited Boehringer Ingelheim RCV
Brammer Bio Cancer Research UK CellGenix
Celltec Clinical Biomanufacturing Facility, Oxford Cobra Biomanufacturing
Covance Eden Biodesign Ltd Emergent Product Development UK Limited
EUFETS AG Eurogentec s.a. FinVectors Vision Therapies
GeneArt/Genovac Genethon Genethon
Genzyme Limited Henogen Henogen
Introgen Invitrogen/Bioreliance Lentigen
Lonza Biologics Microsafe BV Molmed
Nationwide Children's GMP facility Nationwide Children's Viral Vector Core NHSBT, Clinical Biotechnology Centre
Npil Pharmaceuticals (UK) Limited Omnia Biologics, Inc. PacificGMP
Plasmid Factory Polyplus-Transfection Powell Gene Therapy Centre, University of Florida
Protherics UK Limited Qbiogene Qiagen
Quintiles Limited ReiThera Srl Rentschler Biotechnologie
Symbiosis Pharmaceutical Services Targeted Genetics TBF Tissue Engineering

Texcell (Pasteur Institute)

The Goldyne Saved Institute of Gene and therapy, Jerusalem, Israel

Ucb Celltech

Vector Biolabs


Vivebiotech Viral Vector Production Unit VirXsys